Kazia Therapeutics Ltd
ASX:KZA
Kazia Therapeutics Ltd
Revenue
Kazia Therapeutics Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kazia Therapeutics Ltd
ASX:KZA
|
Revenue
AU$22.6k
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-32%
|
|
Immutep Ltd
ASX:IMM
|
Revenue
AU$256.6k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-24%
|
|
Mesoblast Ltd
ASX:MSB
|
Revenue
$7.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Revenue
$14.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Revenue
AU$87.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
25%
|
CAGR 10-Years
42%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Revenue
AU$502.5m
|
CAGR 3-Years
359%
|
CAGR 5-Years
381%
|
CAGR 10-Years
N/A
|
See Also
What is Kazia Therapeutics Ltd's Revenue?
Revenue
22.6k
AUD
Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's Revenue amounts to 22.6k AUD.
What is Kazia Therapeutics Ltd's Revenue growth rate?
Revenue CAGR 10Y
-32%
Over the last year, the Revenue growth was 979%. The average annual Revenue growth rates for Kazia Therapeutics Ltd have been -30% over the past three years , -28% over the past five years , and -32% over the past ten years .